Form 4: AbbVie Director Brett J. Hart Reports Acquisition and Disposal of Shares

Director Brett J. Hart reports acquisition of restricted stock units and disposal of common stock in AbbVie Inc.

Summary

• On May 3, 2024, Brett J. Hart, a director of AbbVie Inc., reported the acquisition of 1,322 restricted stock units (RSUs) under the company's 2013 Incentive Stock Program.
• These RSUs will be paid out in shares of AbbVie common stock upon separation from service, death, or a change in control.
• Hart also disposed of 18,269 shares of common stock on the same date.
• Following these transactions, Hart beneficially owns 1,322 derivative securities and 18,269 shares of AbbVie common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company director, indicating a neutral sentiment.

Future Outlook

The restricted stock units will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common practice for publicly traded companies like AbbVie. It provides transparency to investors regarding the actions of company leadership.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• The transactions themselves may have a minor impact on the stock price, depending on market perception.

Key Dates